SECOND BRAIN Trademark

Trademark Overview


On Monday, October 29, 2018, a trademark application was filed for SECOND BRAIN with the United States Patent and Trademark Office. The USPTO has given the SECOND BRAIN trademark a serial number of 88173138. The federal status of this trademark filing is ABANDONED - AFTER INTER-PARTES DECISION as of Monday, March 9, 2020. This trademark is owned by PathoBiome LLC. The SECOND BRAIN trademark is filed in the Pharmaceutical Products and Medical & Beauty Services & Agricultural Services categories with the following description:

Probiotic supplements; vitamin and mineral supplements; vitamin supplements; whey protein supplements; dietary supplement drink mixes; dietary supplement for eliminating toxins from the intestinal tract; enzyme food supplements; herbal supplements; mineral supplements; multi-vitamin preparations; natural herbal supplements; nutraceuticals for use as a dietary supplement; nutritional supplement for eliminating toxins from the intestinal tract; nutritional supplement shakes; nutritional supplements, namely, probiotic compositions; nutritional supplements, namely, carbohydrates in powdered form; powdered nutritional supplement concentrate; vitamin and mineral supplements in powder, tablet, liquid, capsule or spray form; mineral supplements in powder, tablet, liquid, capsule or spray form; dietary supplements in powder, tablet, liquid, capsule or spray form; food supplements providing a source of vitamins and/or minerals and/or essential fatty acids and/or probiotic cultures in powder, tab...

Medical diagnostic testing services to detect bacteria, fungus, microorganisms, probiotics, cancer and/or pathogens in the gastrointestinal tract; Medical diagnostic testing services to detect bacteria, fungus, microorganisms, probiotics, cancer and/or pathogens in the large intestine; Medical diagnostic testing services to apprise individuals and/or animals of the status of the gastrointestinal tract; Medical diagnostic testing services to apprise individuals and/or animals of the status of the large intestine; providing medical information comprised of a personalized report comparing detected levels of bacteria, fungus, microorganisms, probiotics, cancer and/or pathogen in the gastrointestinal tract; providing medical information comprised of a personalized report comparing detected levels of bacteria, fungus, microorganisms, probiotics, cancer and/or pathogen in the large intestine; providing educational information in the field of the gastrointestinal tract and the existence and re...
second brain

General Information


Serial Number88173138
Word MarkSECOND BRAIN
Filing DateMonday, October 29, 2018
Status604 - ABANDONED - AFTER INTER-PARTES DECISION
Status DateMonday, March 9, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 8, 2019

Trademark Statements


Goods and ServicesProbiotic supplements; vitamin and mineral supplements; vitamin supplements; whey protein supplements; dietary supplement drink mixes; dietary supplement for eliminating toxins from the intestinal tract; enzyme food supplements; herbal supplements; mineral supplements; multi-vitamin preparations; natural herbal supplements; nutraceuticals for use as a dietary supplement; nutritional supplement for eliminating toxins from the intestinal tract; nutritional supplement shakes; nutritional supplements, namely, probiotic compositions; nutritional supplements, namely, carbohydrates in powdered form; powdered nutritional supplement concentrate; vitamin and mineral supplements in powder, tablet, liquid, capsule or spray form; mineral supplements in powder, tablet, liquid, capsule or spray form; dietary supplements in powder, tablet, liquid, capsule or spray form; food supplements providing a source of vitamins and/or minerals and/or essential fatty acids and/or probiotic cultures in powder, tablet, liquid, capsule or spray form; nutritional supplements for human consumption providing a source of vitamins and/or minerals and/or essential fatty acids and/or probiotic cultures in powder, tablet, liquid, capsule or spray form; herbal supplements for general health and well-being, namely, in powder, tablet, liquid, capsule or spray form; preparations in the nature of a vaginal probiotic for the treatment and/or prevention of bacterial or fungal vaginal infection; nutraceuticals for the treatment and/or prevention of bacterial vaginosis, vaginal discharge and odors, for preventing the growth of undesirable micro-organisms that can cause vaginal discharge and odor, killing bacteria that cause bacterial vaginosis, and for maintaining a desirable microflora in the vaginal cavity; micro-organisms culture for medical use, namely, lactic acid bacteria and bifidobacteria having probiotic activity on humans for the treatment of diseases, namely, intestinal disorders, diarrhea and to re-equilibrate the intestinal bacterial flora, for the treatment of intestinal inflammations, inflammatory bowel diseases and inflammations of the lower gastrointestinal tract, for the treatment of ulcerative colitis and Crohn's disease in which inflammation is present both in the small intestine and in the colon; pharmaceutical products containing micro-organisms cultures, namely, lactic acid bacteria and bifidobacteria having probiotic activity on humans for the treatment of diseases, namely, intestinal disorders, diarrhea and to re-equilibrate the intestinal bacterial flora, for the treatment of intestinal inflammations, inflammatory bowel diseases and inflammations of the lower gastrointestinal tract, for the treatment of ulcerative colitis and Crohn's disease in which inflammation is present both in the small intestine and in the colon; pharmaceutical products, namely, probiotic lactic acid bacteria, probiotic bifidobacteria which are able to ferment and use the fibers in the human organism for the treatment of diseases, namely, intestinal disorders, diarrhea and to re-equilibrate the intestinal bacterial flora, for the treatment of intestinal inflammations, inflammatory bowel diseases and inflammations of the lower gastrointestinal tract, for the treatment of ulcerative colitis and Crohn's disease in which inflammation is present both in the small intestine and in the colon, and dietary and nutritional supplements containing microorganisms and cultures of microorganisms, namely, probiotic lactic acid bacteria, probiotic bifidobacteria which are able to ferment and use the fibers in the human organism; pharmaceutical products for oral consumption, namely, capsules, tablets, solutions, suspensions, granules, and pellets in dried form, containing micro-organisms cultures, namely, lactic acid bacteria and bifidobacteria having probiotic activity on humans for the treatment of diseases, including, namely, intestinal disorders, diarrhea and to re-equilibrate the intestinal bacterial flora, for the treatment of intestinal inflammations, inflammatory bowel diseases and inflammations of the lower gastrointestinal tract, for the treatment of ulcerative colitis and Crohn's disease in which inflammation is present both in the small intestine and in the colon, and dietary and nutritional supplements for oral consumption, namely, capsules, tablets, solutions, suspensions, granules, and pellets in dried form, containing micro-organisms cultures, namely, lactic acid bacteria and bifidobacteria having probiotic activity on humans; microbial and biological preparations for improving the physical well-being of humans, namely, reducing inflammation and pain; supplements, namely, dietary supplements, for medical use and baby food, all the above containing preparations and products resulting from the processing of microorganisms, particularly metabolites obtained from the processing of probiotic bacterial cultures; probiotic and/or nutritional and dietary supplements vaginal antifungal preparations; fungal and/or bacterial probiotics, and nutritional supplement for digestive health; nutritional supplement for combating digestive disorders such as Crohn's Disease, ulcerative colitis and irritable bowel syndrome; nutritional supplements, namely, probiotic compositions; diagnostic test kit comprised of medical diagnostic reagents and assays for the detection of bacteria, fungus, microorganisms, probiotics, cancer and/or pathogens in the gastrointestinal tract; diagnostic test kit comprised of medical diagnostic reagents and assays for the detection of bacteria, fungus, microorganisms, probiotics, cancer and/or pathogens in the large intestine; diagnostic colon test kit comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, Crohn's disease, ulcerative colitis, and irritable bowel syndrome; diagnostic colon cancer test kit comprised of medical diagnostic reagents and assays; diagnostic colorectal cancer screening test kit comprised of medical diagnostic reagents and assays; all of the aforementioned supplements and pharmaceutical products for human consumption containing probiotics; all of the aforementioned diagnostic kits testing levels of probiotics
Goods and ServicesMedical diagnostic testing services to detect bacteria, fungus, microorganisms, probiotics, cancer and/or pathogens in the gastrointestinal tract; Medical diagnostic testing services to detect bacteria, fungus, microorganisms, probiotics, cancer and/or pathogens in the large intestine; Medical diagnostic testing services to apprise individuals and/or animals of the status of the gastrointestinal tract; Medical diagnostic testing services to apprise individuals and/or animals of the status of the large intestine; providing medical information comprised of a personalized report comparing detected levels of bacteria, fungus, microorganisms, probiotics, cancer and/or pathogen in the gastrointestinal tract; providing medical information comprised of a personalized report comparing detected levels of bacteria, fungus, microorganisms, probiotics, cancer and/or pathogen in the large intestine; providing educational information in the field of the gastrointestinal tract and the existence and reason for bacteria, fungus, microorganism, probiotics, cancer and/or pathogens in the gastrointestinal tract; providing educational information in the field of the gastrointestinal tract and the existence and reason for bacteria, fungus, microorganism, probiotics, cancer and/or pathogens in the large intestine; providing educational information in the field of the gastrointestinal tract and how to have and maintain and/or monitor a healthy gastrointestinal tract; providing educational information in the field of the gastrointestinal tract and how to have and maintain and/or monitor a healthy large intestine

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code8 - Abandoned
Class Status DateMonday, March 9, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code8 - Abandoned
Class Status DateMonday, March 9, 2020
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBIOHM HEALTH LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressCLEVELAND, OH 44115

Party NameBIOHM HEALTH LLC
Party Type11 - New Owner Before Publication
Legal Entity Type16 - Limited Liability Company
AddressCLEVELAND, OH 44115

Party NamePathoBiome LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressCleveland, OH 44115

Trademark Events


Event DateEvent Description
Monday, March 9, 2020ABANDONMENT NOTICE E-MAILED - INTER PARTES DECISION
Monday, March 9, 2020ABANDONMENT - AFTER INTER PARTES DECISION
Monday, March 9, 2020OPPOSITION TERMINATED NO. 999999
Monday, March 9, 2020OPPOSITION SUSTAINED NO. 999999
Friday, December 6, 2019OPPOSITION INSTITUTED NO. 999999
Tuesday, November 5, 2019EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, October 8, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 8, 2019PUBLISHED FOR OPPOSITION
Wednesday, September 18, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, September 5, 2019ASSIGNED TO LIE
Friday, August 30, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 13, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, August 13, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 13, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, February 28, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, February 28, 2019NON-FINAL ACTION E-MAILED
Thursday, February 28, 2019NON-FINAL ACTION WRITTEN
Monday, February 4, 2019ASSIGNED TO EXAMINER
Wednesday, January 30, 2019AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, November 13, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM